Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04718220 · ClinicalTrials.gov registry record · NA
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
NCT04718220: Completed NA study, sponsored by Washington University School of Medicine.
NCT04718220 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 448 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04718220, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
Study Summary
Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine optimal testing strategies by evaluating the necessity of testing for asymptomatic disease in pregnancy, inform prenatal care plans by assessing the full impact of infection, and contribute to a provider's ability to counsel women and create prenatal care plans if they are pregnant or considering pregnancy.
Primary Outcome
Childbirth prior to 37 weeks of pregnancy, to be determined in accordance to standard pregnancy dating and the established estimated due date.
Interventions
- DIAGNOSTIC_TEST Antibody testing for SARS-CoV-2 IgG
- DIAGNOSTIC_TEST Testing for SARS-CoV-2 RNA
- DIAGNOSTIC_TEST Testing for SARS-CoV-2 IgM/IgG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT04718220 record still lists
NCT04718220 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which Antibody testing for SARS-CoV-2 IgG is the first listed.
NCT04718220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04718220 about?
NCT04718220 is a clinical study titled "Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19". Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine op...
What is the current status of trial NCT04718220?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2021-03-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04718220?
The interventions under investigation include: Antibody testing for SARS-CoV-2 IgG (DIAGNOSTIC_TEST), Testing for SARS-CoV-2 RNA (DIAGNOSTIC_TEST), Testing for SARS-CoV-2 IgM/IgG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04718220?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04718220's enrollment target sits among peer trials
448 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI